India’s Precision Medicine: A Vision Hindered by Biobank Regulations

Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.

Organ-on-chip device Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.

The Promise of Precision Medicine

In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.

India’s Growing Market

The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.

The Biobank Conundrum

Biobank While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.

A Path Forward

To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.

Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Exploring Washington, D.C.’s Premier Real Estate Schools for 2025

In the bustling real estate market of Washington, D.C., aspiring agents are seeking the best education to jumpstart their careers. With its mix of historic charm and modern vibrancy, the capital city offers a unique landscape for real estate professionals. But where does one begin? The answer lies in choosing the right real estate school.

Trump Administration’s Surprise Funding Freeze: Exploring Its Implications

The Trump administration issued a memo late Monday night ordering a temporary freeze on funding for a wide array of federal programs, sending shockwaves through federal agencies and various organizations reliant on government support.

By |October 29, 2025|Categories: Article, Government Policy, Politics|Tags: , |0 Comments

Navigating 2026: Opportunities in Commercial Real Estate Amid Challenges

Despite the ongoing macroeconomic volatility and policy uncertainty that have clouded the global economic outlook, there are avenues for growth for those who can adeptly navigate these complexities.

Finding the Best Real Estate Schools in North Carolina for 2025

In North Carolina, where real estate agents are known as brokers, requires a rigorous 75-hour prelicensing education. This can be pursued online or in person through state-approved schools.

By |October 28, 2025|Categories: Article, Education, Real Estate|Tags: |0 Comments

What to Do If You Fail Your Series 63 Exam: Options and Next Steps

The Series 63 exam can be retaken an unlimited number of times, provided you adhere to the waiting periods set by the North American Securities Administrators Association (NASAA). After an initial failure, a 30-day waiting period is required before you can retake the exam. If you fail a second time, another 30-day wait is necessary. Upon failing three times or more, a longer waiting period of 180 days is enforced.

By |October 27, 2025|Categories: Article, Education, Finance|Tags: , |0 Comments

Fifth Circuit Dismisses CFPB’s Appeal: A Strategic Shift in Regulatory Focus

The U.S. Court of Appeals for the Fifth Circuit has dismissed the appeal by the Consumer Financial Protection Bureau (CFPB) regarding the vacated amendments to its Unfair, Deceptive, or Abusive Acts and Practices (UDAAP) Examination Manual. This decision, made on May 1, aligns with the CFPB’s newly outlined supervision and enforcement priorities for 2025, marking a pivotal shift in the Bureau's regulatory approach.